One of the most serious disabling factors in humans is loss of vision. It is estimated that the total number of such individuals accounts for millions worldwide. The significant spread of such diseases, affecting millions of people around the world, demonstrates the urgency of the issue. More than 1 million people are completely blind in North America alone and about 14 million have some degree of sight loss. There are several different disorders that contribute to loss of vision, such as diabetic retinopathy, senile macular degeneration, Multiple forms of autoimmune retinopathy, harm to the optic nerves and several others. They cannot, as a rule, be fixed with glasses and are not always suitable for drug rehabilitation. The accumulation of different autoantibodies and other metabolites, the large molecules of which do not enable them to be excreted by the kidneys, is often the cause of these diseases and the fact of their accumulation suggests the difficulty of their elimination with the aid of drug therapy. This helps us to use such a form of direct removal from the body as plasmapheresis, and the aim of this study is to explain its use in ophthalmology.
Author (s) Details
V. A. Voinov First I. P. Pavlov State Medical University of St. Petersburg, Russia.
K. S. Karchevscy First I. P. Pavlov State Medical University of St. Petersburg, Russia.
O. V. Isaulov First I. P. Pavlov State Medical University of St. Petersburg, Russia.